Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 293 results for "clinigene"

VIBATIV® targets hospital acquired pneumonia from MRSA across...

Clinigen Group plc announced that the new first-in-class bactericidal, once-daily, injectable lipoglycopeptide antibiotic VIBATIV® (telavancin), is now available to prescribe in Europe for the treatment of adults with nosocomial pneumonia (also ... Hospital Pharmacy Europe, 2 days ago

15 images for clinigene

Mideast Time, 4 weeks ago
Proactive Investors.co.uk, 3 weeks ago
Mideast Time, 1 month ago
Yahoo! UK and Ireland, 1 month ago
Proactive Investors.co.uk, 1 month ago
Proactive Investors.co.uk, 1 month ago
Proactive Investors.co.uk, 1 month ago
Palestine Telegraph, 1 month ago
UK Nigeria Online, 1 month ago
UK Nigeria Online, 1 month ago

BRIEF-Clinigen says Vibativ available in Europe

Sept 18 (Reuters) - Clinigen Group Plc : * New antibiotic Vibativ (telavancin) targets public health priority mrsa infections for people with hospital-acquired pneumonia across Europe * Vibativ is now available to prescribe in Europe for ...
 Reuters UK3 days ago Clinigen shares higher as VIBATIV now available in Europe  Proactive Investors.co.uk3 days ago

Clinigen buys global rights to oncology support therapy, Ethyol from AstraZeneca

Clinigen Group plc, a specialty global pharmaceutical company, has announced the acquisition of the global rights to the oncology support therapy, Ethyol (amifostine) from AstraZeneca. Ethyol is a cytoprotective drug indicated as an adjuvant ...
 PharmaBiz1 month ago Clinigen Group acquires Ethyol (amifostine) global rights from AstraZeneca  Pharmaceutical Business Review1 month ago Clinigen Group acquires Ethyol global rights from AstraZeneca  Big News Network1 month ago

The Expert View: Standard Chartered, SSP and Clinigen

Our daily roundup of the best analyst commentary on shares, also including John Menzies
 Citywire1 month ago
Yahoo! UK and Ireland

Clinigen Group PLC Climbs As It Strengthens Oncology Product Portfolio

Clinigen Group (LSE: CLIN)- aspecialty pharmaceuticals and services business, based in Burton-on-Trent -- announced this morning that it has acquiredglobal rights to Ethyol, an oncology support therapy, from AstraZeneca. At the time of writing ...
 Yahoo! UK and Ireland1 month ago

BRIEF-Clinigen buys AstraZeneca's oncology support drug Ethyol

Aug 20 (Reuters) - Clinigen Group Plc * Clinigen acquires ethyol * Further strengthens oncology support portfolio with acquisition of ethyol (amifostine), from astrazeneca * in 2013, Ethyol revenue was approximately $4.9million Source text ...
 Reuters1 month ago

Clinigen Group Full-Year Underlying EBITDA Up At Least 17% - Quick Facts

Clinigen Group plc (CLIN.L), a company supplying commercial medicines for use in clinical studies, Thursday said its annual underlying EBITDA increased on the back of organic revenue growth, higher gross margins and lower administrative costs. ...
 RTTNews.com1 month ago Clinigen in good health  Insider Media Limited1 month ago CLINIGEN : year end trading update  4 Traders1 month ago Clinigen Group Release: Year End Trading Update  BioSpace1 month ago
Proactive Investors.co.uk

Clinigen : Launches Injectable Antibiotic To Combat Pneumonia

LONDON ( Alliance News ) - Clinigen Group Thursday said it has launched its new injectable antibiotic Vibativ in Europe which aims to treats adults with nosocomial pneumonia, also known as hospital acquired pneumonia. Hospital acquired pneumonia ...
 4 Traders3 days ago Clinigen Launch Antibiotic, Vibativ in Europe  TrustNet3 days ago Clinigen Group plc Clinigen Launch Antibiotic, Vibativ in Europe  ADVFN UK3 days ago Clinigen : Launch Antibiotic, Vibativ in Europe  4 Traders3 days ago
[x]  

Theravance Biopharma Provides VIBATIV(R) (telavancin) Product Update

From the Wires Plans for New Clinical Studies, Expanded Commercial Program and New Study Analyses Further Supporting Drug's in Vitro Potency in Resolving Difficult-to-Treat Infections Sep. 9, 2014 08:05 AM SOUTH SAN FRANCISCO, CA -- ...
 Sys-Con India1 week ago Theravance, Inc. Provides VIBATIV® (telavancin) Product Update  BioSpace1 week ago THERAVANCE BIOPHARMA : Provides VIBATIV(R) (telavancin) Product Update  4 Traders1 week ago Theravance Biopharma, Inc. Reports Second Quarter 2014 Financial Results  Tamar Securities1 month ago
[x]  

CLINIGEN : Buys Oncology Support Therapy from AstraZeneca

By Jana Simmons LONDON--Clinigen Group PLC ( >>Clinigen Group PLC ) , a pharmaceutical company, on Wednesday said it has bought the global rights to oncology support therapy Ethyol (amifostine) from AstraZeneca PLC ( >>AstraZeneca plc ) for an ...
 4 Traders1 month ago Clinigen Group Buys Oncology Support Therapy from AstraZeneca - Update  ADVFN India1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less